With LEAP and the 5 year follow up study, we can feel comfortable deciding to start patients early on levodopa to maximize quality of life via motor symptom control.
In this study there were no differences in UPDRS scores, prevalence of wearing off, or levodopa equivalent daily dose between the ear...